<p><span style="font-family: arial, helvetica, sans-serif; font-size: 16px;">Cervical cancer is one of the most common malignant tumors in the female reproductive system. In 2022, approximately 661,000 new cases were reported worldwide, ranking fourth in the incidence of female malignant tumors; in the same year, there were about 150,700 new cases and 55,700 deaths in China, with the incidence showing an increasing trend year by year. The treatment methods for cervical cancer are diverse, mainly including surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy. For patients with locally advanced cervical cancer (staged ⅠB3, ⅡA2 to ⅣA according to the International Federation of Gynecology and Obstetrics [FIGO] staging system), definitive concurrent chemoradiotherapy is the standard treatment regimen; while patients with early-stage cervical cancer receiving definitive radiotherapy can achieve therapeutic effects comparable to those of surgery. This guideline aims to provide scientific and standardized clinical guidance for radical radiotherapy of cervical cancer in light of China&#39;s national conditions.</span></p>

<p><span style="color: rgba(0, 0, 0, 0.85); font-family: Inter, -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, &quot;PingFang SC&quot;, &quot;Hiragino Sans GB&quot;, &quot;Microsoft YaHei&quot;, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">Despite standardized treatment for cervical cancer, the failure rate remains 30% to 40%. The diagnosis and treatment of recurrent and metastatic cervical cancer (r/mCC) are highly challenging, requiring individualized plans based on various patient-related factors. In recent years, significant progress has been made in the treatment efficacy of r/mCC. Based on this, the Professional Committee of Brachytherapy, Chinese Anti-Cancer Association has compiled these guidelines to provide standardized clinical guidance for clinicians and further improve patient prognosis.</span></p>

<p><span style="font-family: arial, helvetica, sans-serif; font-size: 16px;">The importance of scientific exercise for women during pregnancy and postpartum has become increasingly prominent, as it not only concerns maternal health but also exerts a profound impact on fetal and neonatal development. To standardize clinical practice, the Perinatal Medicine Society of Chinese Medical Association and China Institute of Sport Science, General Administration of Sport of China have jointly developed the&nbsp;Expert Consensus on Exercise for Women During Pregnancy and Postpartum (2025 Edition). Based on the latest international guidelines, evidence-based medical evidence, and China’s national conditions, this consensus was formulated through three rounds of Delphi expert consultation and multidisciplinary discussions. It provides scientifically actionable guidance for exercise intervention in clinical practice and promotes the implementation of the &quot;integration of sports and medicine&quot; concept in maternal health management.</span></p>

<p><span style="font-family: arial, helvetica, sans-serif; font-size: 16px;">Pregnant women typically perceive fetal movements between 16–20 weeks of gestation. Multiple studies have shown that abnormal fetal movement after 28 weeks of gestation is associated with adverse perinatal outcomes. Fetal movement counting is one of the key methods for prenatal monitoring of fetal intrauterine status, helping to identify pathological pregnancies. Timely intervention for abnormal fetal movement is an important part of prenatal care, which can reduce the perinatal mortality rate. To standardize the management of fetal movement during pregnancy and improve pregnancy outcomes, the Perinatal Medicine Society of Chinese Medical Association and the Obstetrics Group of Gynecological and Obstetrical Society of Chinese Medical Association referenced relevant domestic and international academic guidelines and evidence-based medical evidence, organized discussions among national experts, and finally formulated 5 recommendations, aiming to provide a reference for clinical practice.</span></p>